SCHEMBL4343591

SCHEMBL4343591

O=P(O)(O)O[C@H]1[C@H](OP(=O)(O)OP(=O)(O)O)[C@@H](OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@@H](O)[C@@H]1OP(=O)(O)O

nearest known ligand 0.88

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ITPR3 Q14573 9/20 0.74
ITPR1 Q14643 5/20 0.67
ITPR2 Q14571 4/20 0.67
INPP5A Q14642 2/20 0.64
INPPL1 O15357 1/20 0.64
AKT1 P31749 1/20 0.64
SMPD1 P17405 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4343592 1.00 ITPR3 (0.74) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL7035469 0.96 ITPR3 (0.71) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL6664274 0.96 ITPR3 (0.74) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL29930713 0.96 ITPR3 (0.71) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL220555 0.93 ITPR3 (0.67) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL237183 0.93 ITPR3 (0.67) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL219762 0.93 ITPR3 (0.67) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL5056860 0.92 ITPR3 (0.68) ITPR3ITPR1ITPR2INPP5AINPPL1
Scyllitol SCHEMBL5997336 0.91 ITPR3 (0.64) ITPR3ITPR1ITPR2INPP5AINPPL1
SCHEMBL5176539 0.91 ITPR3 (0.65) ITPR3ITPR1ITPR2INPP5AINPPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081521-A1 INOSITOL-BISPYROPHOSPHATE-DERIVED COMPOUNDS AND USES THEREOF NICOLAU YVES CLAUDE (US) 2022-04-21 WO disclosed
EP-2111226-A2 CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS Normoxys, Inc. (US) 2009-10-28 EP disclosed
WO-2008082658-A2 CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS NORMOXYS, INC. (US) 2008-07-10 WO disclosed